Friday, June 10, 2011

A study of Novo Nordisk's off-label marketing of NovoSeven

See these articles:

4-19-11 Annals of Internal Medicine - Systematic Review of Harms and Benefits of Factor VIIa

4-19-11 Annals of Internal Medicine - Off-Label Use of Factor VIIa

No comments:

Post a Comment